1 Primary outcomes |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
1.1 Progression (increase in maximal keratometry) at 12 months after treatment |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.2 Progression (Increase in maximal keratometry) at 36 months after treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2 Secondary outcomes |
2 |
|
Mean Difference (Fixed, 95% CI) |
Totals not selected |
2.1 Mean maximal keratometry in dioptres at 12 months after treatment |
1 |
|
Mean Difference (Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.2 Mean uncorrected visual acuity at 12 months after treatment |
1 |
|
Mean Difference (Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.3 Change in mean corneal thickness (µm) at the thinnest part of the cornea 12 months after treatment |
2 |
|
Mean Difference (Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.4 Mean average corneal power in dioptres at 12 months after treatment |
2 |
|
Mean Difference (Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.5 Mean absolute spherical equivalent at 12 months after treatment |
1 |
|
Mean Difference (Fixed, 95% CI) |
0.0 [0.0, 0.0] |